MTD vs UTHR · P/E 27, rev $1.97B vs P/E 20, rev $1.56B
Mettler-Toledo International Inc (MTD) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the MTD and UTHR stock pages for the full models.
Not investment advice.